Qualcomm stock in focus after proxy filing tees up 24 million-share plan vote ahead of Feb. 4 earnings

Qualcomm stock in focus after proxy filing tees up 24 million-share plan vote ahead of Feb. 4 earnings

New York, January 24, 2026, 18:59 EST — Market closed.

  • Qualcomm shares ended the session at $155.82, slipping 1.25%.
  • A recent proxy filing scheduled a virtual annual meeting for March 17, including a vote on increasing its equity incentive plan by 24 million shares.
  • Qualcomm’s fiscal first-quarter earnings, due Feb. 4 after the U.S. market closes, will be the next major catalyst.

Qualcomm shares slipped 1.25% on Friday, closing at $155.82. Traders cited a mixed day for chip stocks and a new SEC proxy filing highlighting executive pay and stock-based compensation as factors weighing on the stock. With U.S. markets closed Saturday, all eyes now turn to what hurdles Qualcomm faces in the coming week.

The timing is crucial since the proxy triggers shareholder votes impacting pay, dilution, and governance — all just days ahead of investors pivoting to earnings strategies. In the chip space, sentiment can turn on a dime, and Qualcomm remains tied to handset and licensing cycles that still drive part of the sector.

Qualcomm announced in a Jan. 22 filing that its 2026 annual meeting will be held virtually on March 17 at 8:30 a.m. Pacific time, with a record date set for Jan. 16. Shareholders are set to vote on 11 directors, auditor ratification, advisory votes on executive pay, and the frequency of “say-on-pay” votes. The agenda also includes an amended and restated 2023 long-term incentive plan, which would add 24 million shares to the plan’s reserve. Additionally, shareholder proposals cover calling special meetings and a report on the “risk of China exposure.” CEO Cristiano Amon’s total compensation for fiscal 2025 was listed at $29.7 million, up from $25.9 million the previous year. SEC

A proxy statement is the SEC filing where companies detail what shareholders will vote on at the annual meeting, including crucial governance and compensation information. For investors, the equity-plan vote usually carries the most weight: boosting a plan’s “share reserve” lets the company hand out more stock for employee awards, which can dilute current shareholders over time—even if those awards help keep key talent on board.

Qualcomm is pushing more aggressively into “edge AI,” which covers running AI models directly on devices instead of relying on cloud data centers. This strategy aims to expand their narrative beyond just smartphone chips.

On Friday, Abu Dhabi’s Technology Innovation Institute announced a strategic partnership with Qualcomm Technologies, Inc. to push forward edge-AI and autonomous robotics. The collaboration could see Qualcomm’s Dragonwing IQ9 and IQ10 platforms put to use. “By working with advanced edge-AI platforms, TII is expanding the range of autonomous and robotics capabilities we can develop,” said TII CEO Dr. Najwa Aaraj. Qualcomm Abu Dhabi head Dev Singh added the company was “pleased to collaborate” on “autonomous, edge‑AI‑driven systems.” Tii

At Davos, Qualcomm CEO Amon highlighted India’s rise as an electronics manufacturing hub, a trend investors are watching closely as chip and device producers diversify their supply chains across different regions.

Still, risks are clear. A wider semiconductor selloff could easily drown out governance news. Qualcomm also faces volatility from shifts in handset demand and growing concerns over China-related risks, which are directly reflected in this year’s shareholder proposals.

Qualcomm is set to release its fiscal first-quarter 2026 earnings after the market closes on Wednesday, Feb. 4. The company will hold a conference call at 1:45 p.m. Pacific time to discuss the results.

Investors usually zero in on that call to dig into handset demand, licensing revenue trends, and the pace at which newer ventures—like autos, PCs, and industrial edge devices—are starting to generate revenue that could offset the phone cycle’s ups and downs.

QCOM stock faces its next major catalyst on Feb. 4. Proxy votes won’t come until the annual meeting on March 17, but traders will probably focus first on the earnings report and management’s guidance for the remainder of the fiscal year.

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech. Her coverage ranges from stocks and technology to emerging industries and developments across global markets. She studied economics and finance at the London School of Economics and worked in market research before becoming a financial journalist. Follow Khadija Saeed on Google News.

US Stock Market Today Updates

AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 Strong buy

Alphabet

NASDAQ:GOOGL 92/100 • ★★★★½
#2 Strong buy

Taiwan Semiconductor Manufacturing

NYSE:TSM 89/100 • ★★★★½
#3 Buy

S&P Global

NYSE:SPGI 88/100 • ★★★★
#4 Buy on weakness

Amazon

NASDAQ:AMZN 86/100 • ★★★★
#5 Buy on weakness

Microsoft

NASDAQ:MSFT 84/100 • ★★★★
View full portfolio
Editorial model selection. Not personalised advice.
MARKET CALENDAR

Key Events Today

The catalysts most likely to move markets.

#1

U.S. index futures reopen at 18:00 ET

This is the clearest scheduled U.S.-market price-discovery point today and can transmit weekend news into equity-index futures before Monday's cash session.

#2

New Zealand retail sales at 18:45 ET

The Q2 retail package can move NZD and regional risk sentiment. Spillover to U.S. assets is usually secondary unless the result is unusually large.

#3

No scheduled domestic U.S. data or corporate reports

The absence of U.S. releases, earnings, IPO pricings and split events leaves fewer scheduled catalysts, increasing the relative importance of weekend headlines and positioning at the futures reopen.

View full calendar
Times and estimates may change. Verify before trading.
Roche stock price holds near a 52-week high as Jan. 29 results near — what to watch next week
Previous Story

Roche stock price holds near a 52-week high as Jan. 29 results near — what to watch next week

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday
Next Story

ImmunityBio stock tumbles after glioblastoma update; what to watch before Monday